In your clinical practice, approximately how many patients have you treated with Etifoxine?
Based on clinical judgment, what is the response rate among patients treated with Etifoxine?
Which patient profiles have shown the best response to Etifoxine, and which core symptoms showed the most improvement?
What dosage and duration of therapy have you found most effective with Etifoxine?
As per your current usage, in which aspect do you find Etifoxine to be less optimal?
NEWCITA
Which patient profile do you consider most suitable for escitalopram therapy?
What is the usual duration of escitalopram therapy you recommend after achieving remission in MDD?
In patients with depression and comorbid chronic medical conditions (e.g., diabetes, hypertension, obesity), how do you rate escitalopram as a treatment option?
Depression is frequently seen in patients with dermatological disorders, obesity, diabetes, hypertension, terminal illness, or cancer. In such patients, escitalopram is:
